Just In
- 6 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 7 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 10 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 10 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Finance IndusInd Bank Q4 Results: PAT Soars 15% To Rs 2,349 Cr, NII Climbs 15%; 165% Dividend Declared
- Movies Dance Deewane 4: Madhuri Dixit, Suniel Shetty, Karisma Kapoor Dance On Chak Dhoom Dhoom With Chikoo, Bunty- PI
- News Who Is Lisa Pisano, New Jersey Woman Gets Pig Kidney Transplant And Heart Pump?
- Sports Pakistan vs New Zealand 4th T20 Live Score, Latest Updates From Lahore: Tom Blundell, Tim Robinson Open NZ Innings
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Diabetes Drug Can Cause Flesh-Eating Genital Infection, New Study Reveals
According to the latest safety report by the U.S. Food and Drug Administration, a popular diabetes medicine called Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors are found to raise the risk of Fournier gangrene (FG), a flesh-eating infection of the genitals, also known as necrotizing fasciitis of the genitals.
In a period of 5 years between March 2013 to Jan 2019, around 55 cases of FG has been registered in people consuming three different types of approved SGLT2 inhibitors. The names of the inhibitors linked to the cause of Fournier gangrene are as follows:
- Canagliflozin
- Empagliflozin
- Dapagliflozin
- Ertugliflozin
According to the survey, 3 out of 55 people hospitalized for the case of Fournier gangrene died. Among the 55 people, 16 were using dapagliflozin, 21 were taking canagliflozin, and 18 were consuming empagliflozin.
What Study Says
The study author Dr Susan Bersoff-Matcha, a medical officer in the FDA said that the occurrence of FG by taking SGLT2 inhibitors is a rare event, but in one study a link between the two were detected. According to Dr Amesh Adalja, a senior scholar at the Johns Hopkins University Center for Health Security, the disease multiplies at a faster rate and occur mainly in the genital area and also in the anterior abdominal wall [1]
As per the researchers, SGLT2 inhibitors allows the kidney to flush out excess blood sugar through the urine. In the process of lowering the blood glucose, the inhibitors also lower the risk of heart-related diseases. But the side effects due to the drug caused urinary tract infection and other genital infections like fournier gangrene.
11 Miracle Drinks To Manage Diabetes
Jamie Alan, an assistant professor of pharmacology and toxicology at Michigan State University said that, the high level of sugar in any part of the body increases the risk of infection in that particular area because sugar is loved by most of the microorganisms. When the sugar-containing urine passes through the genitals, it becomes an inviting place for the bacteria. However, the infection doesn't spread right away and requires a cut or a wound to spread. After they find an entry, the microorganisms enter through the opening and start spreading. Ultimately, they rot the tissues in the area, causing Fournier Gangrene.
Another researcher who was not included in the study said that, genital infection in a diabetic is common, but FG is extremely rare [2]
The company that makes empagliflozin said that they constantly monitor the side effects of the medicine. However, the prescription of SGLT2 inhibitors have become low due to the risk of FG, said FDA.
- [1] 1. Mallikarjuna, M. N., Vijayakumar, A., Patil, V. S., & Shivswamy, B. S. (2012). Fournier's Gangrene: Current Practices. ISRN surgery, 2012, 942437. doi:10.5402/2012/942437
- [2] 2. Kordahi, A. M., & Suliman, A. S. (2017). A Case of Fournier's Gangrene. Eplasty, 17, ic25.
- disorders cureFournier Gangrene: Causes, Symptoms, Risk factors, Treatment, And Prevention
- healthDelhi Floods: Is It Safe To Swim In Floodwater?
- wellnessCan Drinking Milk After Eating Fish Cause Skin Diseases?
- disorders cureNY Man Treated For Rhinophyma Or Bulbous Nose: Causes, Symptoms And Treatment Of The Condition
- nutritionWorld Vitiligo Day 2021: List Of Foods Which People With Vitiligo Should Eat And Avoid
- disorders cureWhat To Know About Buruli Ulcer: Flesh-Eating Disease Spreading In Australia
- disorders cureWorld Leprosy Day 2021: Facts You Might Not Know About Leprosy
- wellnessNational Scleroderma Awareness Month: Home Remedies For Scleroderma
- disorders cureScleroderma: Types, Causes, Symptoms, Diagnosis, Treatment And Management
- disorders cureAcanthosis Nigricans: Causes, Symptoms, Risk Factors, Diagnosis, Treatment And Prevention
- disorders curePorphyria (The Vampire Syndrome): Causes, Symptoms, Diagnosis, Risk Factors And Treatment
- disorders cureNecrotizing Fasciitis: Causes, Symptoms, Diagnosis, Treatment And Prevention